Hydrocortisone, vitamin C, and thiamine may not improve the outcome of patients with sepsis or septic shock: a systematic review and meta-analysis

Zhuang Li, Xiaoli Zhang, Yongliang Wu, Chao Xie, Chengjiang Liu, Xiuyu He, Zehua Wu, Guofang Hua, Yuedong Li
{"title":"Hydrocortisone, vitamin C, and thiamine may not improve the outcome of patients with sepsis or septic shock: a systematic review and meta-analysis","authors":"Zhuang Li, Xiaoli Zhang, Yongliang Wu, Chao Xie, Chengjiang Liu, Xiuyu He, Zehua Wu, Guofang Hua, Yuedong Li","doi":"10.1097/EC9.0000000000000072","DOIUrl":null,"url":null,"abstract":"Abstract Background This study aimed to conduct a systematic review and meta-analysis of the efficacy of hydrocortisone, vitamin C, and thiamine (HVT) in patients with sepsis or septic shock. Methods A literature search was performed in PubMed, Embase, Cochrane Library, and Web of Science from their inception to April 2021. Search terms included hydrocortisone, thiamine, vitamin C, sepsis, and septic shock. Only randomized controlled trials on HVT in treating sepsis and septic shock were analyzed. Risk ratio (RR) was generated using Review Manager 5.3 to evaluate binary variants, whereas mean ± standard deviation (MD) was generated to assess continuous variants. Results A total of 7 randomized controlled trials, with 1233 patients, were included in this meta-analysis. There was no significant difference in long-term mortality (35.3% vs 33.2%; RR: 1.07; 95% confidence interval [95% CI]: 0.90–1.27; P = 0.45; I2 = 0%), intensive care unit (ICU) mortality (17.4% vs 17.5%; RR: 0.99; 95% CI: 0.75–1.30; P = 0.95; I2 = 0%), in-hospital mortality (27.4% vs 25.8%; RR: 1.06; 95% CI: 0.84–1.34; P = 0.63; I2 = 0%), and acute kidney injury morbidity (RR: 1.04; 95% CI: 0.91–1.18; P = 0.60; I2 = 0%) between HVT and control groups. For continuous variables, there was no significant effect of HVT therapy on delta Sequential Organ Failure Assessment (△SOFA) score (MD: −0.44; 95% CI: −1.00 to 0.12; P = 0.12; I2 = 49%), length of ICU stay (MD: 0.43; 95% CI: −0.27 to 1.14; P = 0.23; I2 = 0%), and length of hospital stay (MD: 0.80; 95% CI: −0.38 to 1.97; P = 0.18; I2 = 0%). Only vasopressor duration was significantly reduced in the HVT group (MD: −17.75; 95% CI: −25.56 to −9.94; P < 0.00001; I2 = 38%). Vasopressor duration refers to the time to shock reversal. Alternatively, it is the amount of time (in hours) required for patients to withdraw all vasoactive medication support. Neither HVT nor control △SOFA reached statistical significance. Conclusion Hydrocortisone, vitamin C, and thiamine use was not associated with improved mortality, lower acute kidney injury incidence, lower △SOFA, and shorter ICU and in-hospital stays among patients with sepsis and septic shock. However, the use of vasopressors decreased significantly. Further direct head-to-head studies are needed.","PeriodicalId":72895,"journal":{"name":"Emergency and critical care medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emergency and critical care medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/EC9.0000000000000072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Abstract Background This study aimed to conduct a systematic review and meta-analysis of the efficacy of hydrocortisone, vitamin C, and thiamine (HVT) in patients with sepsis or septic shock. Methods A literature search was performed in PubMed, Embase, Cochrane Library, and Web of Science from their inception to April 2021. Search terms included hydrocortisone, thiamine, vitamin C, sepsis, and septic shock. Only randomized controlled trials on HVT in treating sepsis and septic shock were analyzed. Risk ratio (RR) was generated using Review Manager 5.3 to evaluate binary variants, whereas mean ± standard deviation (MD) was generated to assess continuous variants. Results A total of 7 randomized controlled trials, with 1233 patients, were included in this meta-analysis. There was no significant difference in long-term mortality (35.3% vs 33.2%; RR: 1.07; 95% confidence interval [95% CI]: 0.90–1.27; P = 0.45; I2 = 0%), intensive care unit (ICU) mortality (17.4% vs 17.5%; RR: 0.99; 95% CI: 0.75–1.30; P = 0.95; I2 = 0%), in-hospital mortality (27.4% vs 25.8%; RR: 1.06; 95% CI: 0.84–1.34; P = 0.63; I2 = 0%), and acute kidney injury morbidity (RR: 1.04; 95% CI: 0.91–1.18; P = 0.60; I2 = 0%) between HVT and control groups. For continuous variables, there was no significant effect of HVT therapy on delta Sequential Organ Failure Assessment (△SOFA) score (MD: −0.44; 95% CI: −1.00 to 0.12; P = 0.12; I2 = 49%), length of ICU stay (MD: 0.43; 95% CI: −0.27 to 1.14; P = 0.23; I2 = 0%), and length of hospital stay (MD: 0.80; 95% CI: −0.38 to 1.97; P = 0.18; I2 = 0%). Only vasopressor duration was significantly reduced in the HVT group (MD: −17.75; 95% CI: −25.56 to −9.94; P < 0.00001; I2 = 38%). Vasopressor duration refers to the time to shock reversal. Alternatively, it is the amount of time (in hours) required for patients to withdraw all vasoactive medication support. Neither HVT nor control △SOFA reached statistical significance. Conclusion Hydrocortisone, vitamin C, and thiamine use was not associated with improved mortality, lower acute kidney injury incidence, lower △SOFA, and shorter ICU and in-hospital stays among patients with sepsis and septic shock. However, the use of vasopressors decreased significantly. Further direct head-to-head studies are needed.
氢化可的松、维生素C和硫胺素可能不会改善败血症或感染性休克患者的预后:一项系统综述和荟萃分析
摘要背景本研究旨在对氢化可的松、维生素C和硫胺素(HVT)治疗败血症或感染性休克患者的疗效进行系统综述和荟萃分析。方法检索PubMed、Embase、Cochrane图书馆和Web of Science从成立到2021年4月的文献。搜索词包括氢化可的松、硫胺素、维生素C、败血症和感染性休克。仅对HVT治疗败血症和感染性休克的随机对照试验进行了分析。使用Review Manager 5.3生成风险比(RR)以评估二元变异,而生成平均值±标准差(MD)以评估连续变异。结果本荟萃分析共纳入7项随机对照试验,共1233名患者。长期死亡率(35.3%vs 33.2%;RR:1.07;95%置信区间[95%CI]:0.90-1.27;P=0.45;I2=0%)、重症监护室(ICU)死亡率(17.4%vs 17.5%;RR:0.99;95%CI:0.75-1.30;P=0.95;I2=0%)、住院死亡率(27.4%vs 25.8%;RR:1.06;95%CI:0.84-1.34;P=0.63;I2=0)无显著差异,HVT组和对照组之间的急性肾损伤发病率(RR:1.04;95%CI:0.91–1.18;P=0.60;I2=0%)。对于连续变量,HVT治疗对delta顺序器官衰竭评估没有显著影响(△SOFA)评分(MD:−0.44;95%CI:−1.00至0.12;P=0.12;I2=49%)、ICU住院时间(MD:0.43;95%CI:−0.27至1.14;P=0.23;I2=0%)和住院时间(MD:0.80;95%CI:−0.38至1.97;P=0.18;I2=0%)。HVT组仅血管升压持续时间显著缩短(MD:−17.75;95%CI:−25.56至−9.94;P<0.00001;I2=38%)。升压持续时间是指电击逆转的时间。或者,它是患者撤回所有血管活性药物支持所需的时间(以小时为单位)。既不是HVT也不是控制△SOFA达到统计学显著性。结论氢化可的松、维生素C和硫胺素的使用与提高死亡率、降低急性肾损伤发生率、△SOFA,以及败血症和感染性休克患者更短的ICU和住院时间。然而,血管升压药的使用显著减少。需要进一步的直接面对面研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信